Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AMPE > SEC Filings for AMPE > Form 8-K on 19-Jul-2013All Recent SEC Filings

Show all filings for AMPIO PHARMACEUTICALS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for AMPIO PHARMACEUTICALS, INC.


19-Jul-2013

Entry into a Material Definitive Agreement, Change in Directors or Pr


Item 1.01. Entry into a Material Definitive Agreement.

The information set forth under Item 5.02 of this Current Report on Form 8-K is hereby incorporated in this Item 1.01 by reference.



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Amendment of Employment Agreement with David Bar-Or, M.D.

On July 15, 2013, Ampio Pharmaceuticals, Inc. (the "Company") entered into an amendment to the Employment Agreement, dated August 1, 2010 with David Bar-Or, M.D. (the "Bar-Or Amendment", and the Employment Agreement as amended, the "Bar-Or Employment Agreement"). Under the Bar-Or Amendment, the term of Dr. Bar-Or's Employment Agreement was extended through July 31, 2014. In addition, in connection with the Bar-Or Amendment, Dr. Bar-Or was granted an option to purchase 300,000 shares of the Company's Common Stock. The option is exercisable for a period of ten years at an exercise price per share equal to the quoted closing price of the Company's common stock on July 15, 2013. The option vests as follows: 150,000 shares on the date of grant and 150,000 shares on the first anniversary of the date of grant, subject to vesting acceleration provisions in accordance with the Bar-Or Employment Agreement.

The description of the Bar-Or Amendment set forth herein does not purport to be complete and is qualified in its entirety by reference to the full text thereof, which is attached hereto as Exhibit 10.1.

Amendment of Employment Agreement with Vaughan Clift, M.D.

On July 15, 2013, the Company entered into an amendment to the Employment Agreement, dated August 1, 2010, as subsequently amended, with Vaughan Clift, M.D. (the "Clift Amendment", and the Employment Agreement as amended, the "Clift Employment Agreement"). Under the Clift Amendment, the term of Dr. Clift's Employment Agreement was extended through July 31, 2014. In addition, in connection with the Clift Amendment, Dr. Clift was granted an option to purchase 170,000 shares of the Company's Common Stock. The option is exercisable for a period of ten years at an exercise price per share equal to the quoted closing price of the Company's common stock on July 15, 2013. The option vests as follows: 85,000 shares on the date of grant and 85,000 shares on the first anniversary of the date of grant, subject to vesting acceleration provisions in accordance with the Clift Employment Agreement.

The description of the Clift Amendment set forth herein does not purport to be complete and is qualified in its entirety by reference to the full text thereof, which is attached hereto as Exhibit 10.2.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

10.1    Amendment to Employment Agreement between Ampio Pharmaceuticals, Inc. and
        David Bar-Or, M.D., dated July 15, 2013

10.2    Amendment to Employment Agreement between Ampio Pharmaceuticals, Inc. and
        Vaughan Clift, M.D., dated July 15, 2013


  Add AMPE to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AMPE - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.